AIM
AMAG

Alambic Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Alambic Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,959
Closed -$227K – 419
2018
Q4 		$227K Buy
+14,959
New +$285K 0.1% 242
2018
Q2 		– Sell
-45,019
Closed -$907K – 498
2018
Q1 		$907K Sell
45,019
-17,537
-28% -$297K 0.13% 237
2017
Q4 		$829K Sell
62,556
-88,886
-59% -$1.34M 0.1% 267
2017
Q3 		$2.79M Buy
151,442
+76,842
+103% +$1.43M 0.31% 118
2017
Q2 		$1.37M Buy
+74,600
New +$1.48M 0.17% 207

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Alambic Investment Management's AMAG Position: Q1 2019 in Review

Alambic Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 14,959 shares — an estimated $227K sold.

Alambic Investment Management first reported a position in AMAG in Q2 2017 and held it in 5 quarters. The position peaked at $2.79M in Q3 2017. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

  • Alambic Investment Management reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Alambic Investment Management sold 14,959 AMAG Pharmaceuticals shares in Q1 2019, an estimated $227K.
  • Alambic Investment Management first reported a position in AMAG Pharmaceuticals in Q2 2017 and held it in 5 quarters.
  • Alambic Investment Management's AMAG Pharmaceuticals position peaked at $2.79M in Q3 2017.
  • 166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Alambic Investment Management's 13F filing for Q1 2019, filed 9 May 2019.